A detailed history of Global Financial Private Client, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Global Financial Private Client, LLC holds 318 shares of BSX stock, worth $28,620. This represents 0.01% of its overall portfolio holdings.

Number of Shares
318
Previous 200 59.0%
Holding current value
$28,620
Previous $15.4 Million 73.02%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$72.96 - $84.0 $8,609 - $9,912
118 Added 59.0%
318 $26.6 Million
Q3 2023

May 15, 2024

SELL
$50.19 - $54.68 $241,564 - $263,174
-4,813 Reduced 96.01%
200 $10.6 Million
Q2 2023

May 15, 2024

BUY
$49.72 - $54.64 $35,848 - $39,395
721 Added 16.8%
5,013 $268 Million
Q1 2023

May 15, 2024

BUY
$45.09 - $50.03 $184,508 - $204,722
4,092 Added 2046.0%
4,292 $213 Million
Q4 2022

May 15, 2024

BUY
$39.56 - $47.22 $7,912 - $9,444
200 New
200 $9.25 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Global Financial Private Client, LLC Portfolio

Follow Global Financial Private Client, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Financial Private Client, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Financial Private Client, LLC with notifications on news.